In contrast to the other AML genes, TP53 was mutated in most patients in the HRMS, but not in any other patients, constituting a highly significant difference ( Table 1 ).
← all excerpts
Molecular Characterization of the Highest Risk Adult Patients With Acute Myeloid Leukemia (AML) Through Multi-Omics Clustering.
1
—
—